This inventor holds 2 USPTO granted patents. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2004-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2007
Title: Boaz Tirosh: Innovator in Controlled Release Drug Delivery Systems
Introduction
Boaz Tirosh is a notable inventor based in Holon, Israel. He has made significant contributions to the field of drug delivery systems, particularly focusing on controlled release mechanisms. With a total of 2 patents, Tirosh's work is paving the way for advancements in pharmaceutical technology.
Latest Patents
Tirosh's latest patents include innovative systems for controlled release oral drug delivery. The first patent describes a synchronous drug delivery composition that features a polymeric matrix made from hydrogel blended with a hydrophobic polymer. This erodible matrix allows for the synchronous release of the drug, hydrogel, and agents that enhance intestinal drug absorption or inhibit intestinal drug degradation. The second patent also focuses on a controlled release drug delivery system that utilizes a polymeric matrix capable of eroding in the gastrointestinal tract. This system is designed to protect drugs from enzymatic degradation while enhancing their absorption across intestinal mucosal tissues.
Career Highlights
Boaz Tirosh is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this esteemed institution has allowed him to collaborate with leading researchers and contribute to groundbreaking innovations in drug delivery.
Collaborations
Some of Tirosh's notable coworkers include Abraham Rubinstein and Michael M. Friedman. Their collaborative efforts have further enriched the research and development of advanced drug delivery systems.
Conclusion
Boaz Tirosh's contributions to controlled release drug delivery systems highlight his innovative spirit and dedication to improving pharmaceutical technologies. His patents represent significant advancements that could enhance patient care and treatment efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
